Medical disclaimer: This article is for general informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Erectile dysfunction has multiple possible causes, many of which require clinical evaluation. Consult a licensed physician for proper assessment and individualized guidance.
Erectile dysfunction affects an estimated 30 million men in the United States alone, yet most conversations about it jump straight to treatment options — usually a pill — without asking a more useful question first: what’s actually driving it? The answer matters, because ED is rarely just a mechanical problem. In many men, it’s a signal that something is off upstream — in the hormonal, vascular, or neurological systems that make erections possible in the first place.
Hormones are a frequently overlooked part of that picture. Not the only part — but a significant one. This article breaks down how the hormonal system intersects with erectile function, which hormonal imbalances are most commonly involved, and how they fit alongside the other major causes of ED.
How Erections Actually Work
Understanding where hormones fit requires a quick primer on the mechanics. An erection depends on the coordinated interaction of three systems: neurological (nerve signals from the brain and spinal cord), vascular (blood flow into and pressure within the penis), and hormonal (signaling that influences libido, nerve sensitivity, and vascular tone).
Sexual arousal triggers the release of nitric oxide in the smooth muscle of the penile arteries. This causes vasodilation — the vessels relax and widen, allowing blood to fill the erectile tissue (corpus cavernosum). At the same time, venous outflow is restricted, maintaining the pressure that produces and sustains an erection.
Hormones influence multiple steps in this process. Testosterone affects libido (the motivational drive toward sexual activity), dopamine signaling in the brain, nitric oxide synthase activity in penile tissue, and the sensitivity of nerve endings. When testosterone falls below optimal levels, the entire process becomes less efficient — even if the vascular and neurological components are intact.
The Hormonal Causes of ED — What the Evidence Shows
Low Testosterone (Hypogonadism)
Testosterone is the most studied hormonal contributor to erectile function. Research consistently shows that men with confirmed hypogonadism — clinically low testosterone — have higher rates of erectile dysfunction than age-matched men with normal testosterone levels. A meta-analysis published in the Journal of Sexual Medicine found that testosterone deficiency was present in a meaningful proportion of men presenting with ED, particularly those with reduced libido alongside their erection difficulties.
The relationship isn’t entirely straightforward. Some men with low testosterone maintain erectile function; others with borderline levels experience significant symptoms. This is partly because testosterone affects both the central (brain-based desire and arousal) and peripheral (penile tissue sensitivity and vascular function) components of erection differently. Men whose ED is primarily libido-driven — reduced desire rather than mechanical failure — are more likely to have a testosterone-related component.
Testosterone converts to estradiol (a form of estrogen) via the aromatase enzyme, particularly in fat tissue. In men with higher body fat, this conversion can be excessive, leading to an imbalanced testosterone-to-estrogen ratio. Elevated estradiol in men is associated with reduced libido, gynecomastia (breast tissue growth), and impaired erectile function — not because estrogen itself is harmful at physiological levels, but because the imbalance suppresses effective androgenic signaling.
This is one reason why body composition and hormonal health are closely linked. Men addressing obesity or metabolic dysfunction often see improvements in hormonal balance — and in some cases, improvements in sexual function — alongside weight changes.
Elevated Prolactin
Prolactin is a pituitary hormone typically associated with lactation, but it’s present in men at low levels and plays a role in regulating testosterone and sexual function. Elevated prolactin (hyperprolactinemia) suppresses GnRH and LH, reducing testosterone production and often causing reduced libido and ED. Causes include pituitary tumors (prolactinomas), certain medications, hypothyroidism, and chronic stress. It’s less common than testosterone deficiency but frequently missed because prolactin isn’t included in standard hormone panels.
Thyroid Dysfunction
Both hypothyroidism (underactive thyroid) and hyperthyroidism (overactive thyroid) have been associated with sexual dysfunction in men. Thyroid hormones influence testosterone metabolism, vascular function, and neurological signaling. A 2008 study published in the Journal of Clinical Endocrinology & Metabolism found that thyroid dysfunction was significantly more common in men with ED compared to controls, and that thyroid treatment improved erectile function in affected men.
Low Growth Hormone / IGF-1
Growth hormone deficiency is less commonly discussed in the context of ED but has documented associations with reduced sexual function, lower libido, and impaired quality of life. GH and IGF-1 influence nitric oxide production in vascular tissue — the same pathway that drives penile blood flow. For context on how growth hormone deficiency presents and is evaluated, the article on 7 signs your growth hormone levels may be low covers the clinical picture in detail.
Hormonal factors associated with erectile dysfunction
🔵 Low Testosterone Reduces libido, nitric oxide activity, and penile sensitivity — most common hormonal cause
🟠 Elevated Estradiol High T-to-E2 conversion (often from excess body fat) suppresses androgen signaling
🟣 High Prolactin Suppresses LH and testosterone; often caused by pituitary tumors or medications
🟡 Thyroid Dysfunction Both hypo- and hyperthyroidism linked to ED; often reversible with thyroid treatment
🟢 Low GH / IGF-1 Impairs nitric oxide production and vascular tone; associated with reduced sexual function
Fig. 1 — Hormonal contributors to ED. These associations are based on peer-reviewed research. Identifying which factor is involved requires clinical evaluation and laboratory testing.
Hormonal ED vs. Vascular and Psychological ED
Hormones don’t operate in isolation. Erectile dysfunction in most men over 40 involves more than one contributing factor, and determining the relative weight of each requires a structured evaluation — not symptom matching alone.
The three main categories of ED overlap significantly in presentation but differ in their underlying mechanisms and in what improves them.
[Insert Table 1 here as native WP Table block — see data in file comments above]
The distinction between hormonal and vascular ED is clinically significant. A man with low testosterone whose primary complaint is reduced desire and difficulty initiating erections may respond differently to treatment than a man with normal testosterone whose ED is driven by endothelial dysfunction from diabetes. PDE5 inhibitors (like sildenafil) work on the vascular side — they don’t address hormonal deficiency. Men whose ED has a significant hormonal component who take PDE5 inhibitors without addressing the hormonal cause often see partial or unsustained improvement.
What Low Testosterone–Related ED Actually Looks Like
Recognizing the pattern matters because it determines which questions to ask and which labs to order. Hormonal ED tends to present with a constellation of symptoms rather than ED in isolation.
The typical hormonal ED pattern
Reduced or absent libido alongside erection difficulties — desire and function decline together
Changes in body composition — increased abdominal fat, reduced muscle mass
Morning erections less frequent or less rigid than previously
Gradual onset over months or years rather than sudden change
By contrast, ED with preserved or near-normal libido — where desire is present but execution is unreliable — is more likely to have a vascular or psychological component.
Clinical pattern: hormonal ED vs. vascular ED — key differences
HORMONAL Libido reduced Desire and function decline together — “don’t want to” as much as “can’t”
HORMONAL Gradual onset Symptoms develop over months/years alongside fatigue, mood changes, body composition shifts
VASCULAR Libido intact Desire present but execution unreliable — mechanical rather than motivational
VASCULAR Cardiovascular risk factors Often co-exists with hypertension, diabetes, high cholesterol, or smoking history
BOTH Morning erections reduced Absent or reduced morning erections suggest physiological (not purely psychological) cause
Fig. 2 — Pattern differences for educational orientation. Mixed presentations are common in men over 40. Only laboratory testing and clinical evaluation can determine the underlying cause.
What a Proper Evaluation Looks Like
ED is a symptom, not a diagnosis. An evaluation aimed at identifying the cause — rather than just treating the symptom — typically includes a combination of clinical history, physical examination, and targeted laboratory testing.
Relevant lab markers in a hormonal ED workup
Total and free testosterone — total testosterone gives the overall picture; free testosterone accounts for binding proteins (SHBG) that affect how much is biologically active
LH and FSH — pituitary hormones that determine whether low testosterone is primary (testicular) or secondary (pituitary/hypothalamic) in origin
Prolactin — elevated levels point to pituitary pathology or medication effects
Estradiol (E2) — assesses aromatization and T-to-E2 ratio
SHBG — sex hormone-binding globulin affects free testosterone availability
Thyroid panel (TSH, free T4) — thyroid dysfunction is a common and treatable contributor
Fasting glucose and HbA1c — diabetes is the leading vascular cause of ED
Lipid panel — cardiovascular risk assessment
A thorough hormonal evaluation also provides the baseline needed before considering any hormonal intervention. For an overview of how testosterone therapy is evaluated and managed, the testosterone therapy overview explains the diagnostic process in detail. For men where growth hormone may also be a factor, the HGH therapy overview covers that evaluation pathway.
The Bidirectional Relationship: ED as a Health Signal
ED in men over 40 is increasingly recognized by physicians as a potential early indicator of cardiovascular disease. The arteries supplying the penis are smaller than coronary arteries — endothelial dysfunction and early atherosclerosis typically show up there first, sometimes 3–5 years before cardiac symptoms develop. A study published in Circulation found that ED was an independent predictor of cardiovascular events in men, even after controlling for traditional risk factors.
This matters because it reframes how ED should be approached. Rather than a quality-of-life problem to be managed with a prescription, it can be a clinical signal warranting a broader cardiovascular and metabolic evaluation. The same lifestyle and metabolic factors that drive cardiovascular disease — obesity, insulin resistance, dyslipidemia, hypertension — also impair both hormonal and vascular contributions to erectile function.
Can low testosterone cause ED even if I still have some sexual interest?
Yes. The relationship between testosterone and erectile function operates through multiple pathways — libido is one of them, but not the only one. Testosterone influences nitric oxide activity in penile tissue, dopamine signaling in the brain, and nerve sensitivity — all of which contribute to erection quality independent of desire. Men with moderately low testosterone may maintain some libido but notice reduced rigidity, slower arousal, or less reliable erections.
Does ED mean my testosterone is low?
Not necessarily — ED has many causes, and testosterone deficiency is one of several. Studies suggest that frank hypogonadism is present in a minority of men with ED (estimates range from 5–35% depending on the population studied). However, in men whose ED is accompanied by reduced libido, fatigue, mood changes, or body composition shifts, the likelihood of a hormonal component is meaningfully higher. A lab panel is the only reliable way to determine whether testosterone is involved.
Will testosterone therapy fix ED?
In men with confirmed testosterone deficiency and ED that has a hormonal component, restoring testosterone to a healthy physiological range often improves libido and can improve erectile function — particularly the desire-driven aspects. It is less reliably effective for ED that is primarily vascular. Some men with both hormonal and vascular components see additive improvement when hormonal deficiency is addressed alongside vascular treatment. This is a clinical determination that requires proper evaluation, not a blanket answer.
Can ED be caused by high estrogen?
Elevated estradiol relative to testosterone can contribute to reduced libido and erectile difficulties in men. This is more commonly seen in men with higher body fat (which drives aromatase activity), those on testosterone therapy without adequate monitoring, or men using certain medications or supplements. Estradiol assessment is part of a comprehensive hormonal ED workup.
Is psychological ED different from hormonal ED?
Yes, though they can coexist and reinforce each other. Psychological ED typically has a situational pattern — erections are possible in some contexts (e.g., during solo arousal or upon waking) but not others. Morning erections are often preserved. Onset usually correlates with a stressful life event, relationship issue, or performance anxiety. Hormonal ED tends to affect function more globally and is accompanied by other symptoms. In practice, chronic ED of any cause can develop a psychological overlay over time.
Does diabetes cause ED through hormones?
Diabetes causes ED primarily through vascular and neurological pathways — damaging blood vessels and nerves involved in erection — rather than through hormonal mechanisms directly. However, men with diabetes also have higher rates of testosterone deficiency, partly because insulin resistance and metabolic dysfunction affect the HPG axis. So in diabetic men with ED, both vascular and hormonal factors frequently need to be evaluated.
At what age does hormonal ED typically begin?
There is no fixed age. Testosterone decline begins gradually in the mid-30s. ED attributable primarily to hormonal causes can appear in the 40s, though it’s more common in the 50s and beyond as the cumulative decline becomes more clinically significant. Younger men can have hormonal ED if they have primary hypogonadism, pituitary disorders, or significant metabolic dysfunction. Age is a risk factor, but the symptom pattern and lab results matter more than age alone.
If ED is the only symptom and libido is normal, is it still worth checking testosterone?
A baseline testosterone level is reasonable as part of a comprehensive ED workup, even when libido is preserved. Some men maintain desire at lower testosterone levels but experience peripheral effects (reduced nitric oxide activity, impaired penile sensitivity) without a marked reduction in subjective desire. Additionally, identifying low testosterone early provides clinically relevant information beyond just ED — testosterone affects bone density, cardiovascular health, body composition, and mood. The information is useful regardless of whether testosterone turns out to be the primary driver of the ED.
References
Buvat J, Maggi M, Guay A, Torres LO. Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment. J Sex Med. 2013;10(1):245–284. doi:10.1111/j.1743-6109.2012.02783.x
Corona G, Isidori AM, Buvat J, et al. Testosterone supplementation and sexual function: a meta-analysis study. J Sex Med. 2014;11(6):1577–1592. doi:10.1111/jsm.12536
Kapoor D, Aldred H, Clark S, Channer KS, Jones TH. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes. Diabetes Care. 2007;30(4):911–917. doi:10.2337/dc06-1426
Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423–432. doi:10.1016/j.juro.2018.03.115
Yafi FA, Jenkins L, Albersen M, et al. Erectile dysfunction. Nat Rev Dis Primers. 2016;2:16003. doi:10.1038/nrdp.2016.3
Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA. Erectile dysfunction and subsequent cardiovascular disease. JAMA. 2005;294(23):2996–3002. doi:10.1001/jama.294.23.2996
Krassas GE, Tziomalos K, Papadopoulou F, Pontikides N, Perros P. Erectile dysfunction in patients with hyper- and hypothyroidism: how common and should we treat? J Clin Endocrinol Metab. 2008;93(5):1815–1819. doi:10.1210/jc.2007-2259
